Commitment to collaborative infectious disease research – The Clinical Virology Network

Since 2009, MEDEORA has been supporting the Clinical Virology Network (CVN) – not merely as a technical partner, but as an active contributor to data-driven, collaborative infectious disease research. Our contribution ranges from the development of high-performance data infrastructures to the ongoing refinement of organisational processes that facilitate the seamless exchange of information between laboratories, the scientific community and public health authorities.

The Clinical Virology Network connects doctors, laboratories and research institutions across institutional and geographical boundaries. Its aim is to identify emerging trends in the spread of infectious agents at an early stage and to provide reliable data to support informed decision-making.

What began as a network for monitoring respiratory infections has been steadily expanded:
Since 2014, the CVN has also covered bacterial pathogens, and since 2016 it has included a specialised gastroenteritis network. Today, the CVN is an established tool supporting national surveillance systems in Germany, Austria and Switzerland, and contributes significantly to transparency and scientific exchange through freely accessible, up-to-date data.

Around 50 laboratories have contributed data so far, with around 25 currently submitting their results digitally on a regular basis within a few days. Around 300,000 additional test results are fed into the system every month – bringing the total to over a million records, including both positive and negative results, which enable reliable calculation of positivity rates. There is close cooperation with the Robert Koch Institute.

👉 Project page: https://public.clinical-virology.net

Making data visible – dashboards for evidence-based decision-making

A key part of our work involves transforming complex data into intuitive, publicly accessible visualisations. The dashboards supported by MEDEORA provide transparency and enable both experts and the general public to track epidemiological trends in near real time.

Focus on respiratory diseases

The dashboard for respiratory viruses and bacteria provides continuously updated insights into infection rates, seasonal patterns and regional distributions. It helps healthcare professionals and public health authorities to identify trends at an early stage and respond effectively. At the same time, it contributes to the evaluation of prevention measures and vaccination strategies.

👉 :
https://www.arcgis.com/apps/dashboards/2a29f2bebc524c67b6250b64beea12bf

Understanding gastrointestinal infections

The specialised gastrointestinal dashboard enables detailed analysis of the prevalence, dynamics and severity of gastrointestinal infections. It provides a robust data foundation for diagnosis, treatment decisions and health policy measures, thereby supporting evidence-based patient care.

👉 Gastrointestinal Dashboard:
https://medeora.maps.arcgis.com/apps/dashboards/1435c35e55284cdea04a1ad034b00d8c

Research impact and visibility

MEDEORA’s involvement in the CVN is also reflected in a growing number of scientific publications. The data generated within the network provides the basis for high-quality research and contributes to international visibility.

A selection of recent publications:

• Sharp increase in Chlamydia pneumoniae infections in 2025 in Germany
  Boutin S. et al., European Journal of Clinical Microbiology & Infectious Diseases (2025)
• Long-term impact of the SARS-CoV-2 pandemic on respiratory viruses in Germany
  Eggeling R. et al., BMC Public Health (2025)
• Respiratory Viruses Dynamics and Interactions: Ten Years of Surveillance in Central Europe
  Horemheb-Rubio G. et al., BMC Public Health (2022)
• A recent review study on RSV surveillance systems in Germany explicitly highlights the CVN as a relevant data source – significant evidence of the network’s scientific relevance.

Further publications are in the pipeline.

👉 Further information:
https://public.clinical-virology.net/news/

Our mission

Our commitment is driven by the conviction that high-quality data, open structures and interdisciplinary collaboration are crucial to effectively tackling infectious diseases.

MEDEORA sees itself not merely as a software provider, but as a long-term partner for modern, interconnected and transparent health research.